Variations in the frequency of complex ventricular arrhythmias were evaluated by consecutive 24-hour long-term electrocardiographic recordings over 4 days using a two-channel recorder and computerassisted analysis system with a weighted relative mean error of 7.5 i 5% (SD). Twenty patients (mean age 58 ± 9 years [SD]) with various cardiac disorders were selected if they had a daily average of more than 30 ventricular ectopic complexes per hour. Twenty patients had ventricular couplets and 14 patients had ventricular tachycardia (at least triplets). The mean daily number of either couplets or ventricular tachycardia was subjected to a four-factor nested analysis of variance to determine the sources of variation in ectopic frequency. Differences in hourly rates accounted for 30% of the variation in the frequency of ectopic complexes. Statistical methods were applied to determine the change in frequency of complex arrhythmias necessary to exceed that attributable to spontaneous variation alone at the p < 0.05 level. Using a typical protocol, for example, comparing a 24-hour test period with a 24-hour control period would require a 65% decrease in mean hourly frequency of ventricular tachycardia and 75% reduction in the frequency of couplets to demonstrate therapeutic efficacy rather than a reduction due to spontaneous variation alone.
LONG-TERM ambulatory electrocardiographic recording has gained wide acceptance as an effective means of detecting arrhythmias and monitoring antiarrhythmic therapy.' Only recently, however, have statistical methods been applied to the analysis of arrhythmias.4 5 These analyses have shown that marked spontaneous hour-to-hour and day-to-day variability in arrhythmia frequency may occur, and that rigid guidelines must be followed if one is to be confident that an observed reduction in the frequency of ectopic complexes is actually attributable to therapeutic intervention. The present study was designed to determine the extent to which such spontaneous variability occurs in the frequency of complex ventricular arrhythmias (e.g., couplets and ventricular tachycardia) in otherwise clinically stable cardiac patients with frequent ectopy.
Methods and Materials
Four consecutive, 24-hour, long-term ambulatory electrocardiographic recordings were obtained from 20 patients using a simultaneous two-channel (modified precordial leads V, and V5) Avionics 445 recorder. Two patients were also monitored during a second 4-day period. Before entry into a study of a new antiarrhythmic drug, patients were selected for the presence of frequent ventricular ectopy: mean frequency . 30 ectopic complexes/hour during the initial 24-hour recording period, range 35-1791 ventricular ectopic complexes/hour with a mean of 438 ± 523 ventricular ectopic complexes/hour (SD) during the 4-day monitoring period. The patients were ages 39-71 years with a mean of 58 ± 9 years (SD); 16 were male. Diagnoses included atherosclerotic cardiovascular disease (previous myocardial infarction or positive coronary angiography) in seven patients, hypertensive cardiovascular disease in seven patients, congestive cardiomyopathy in two patients and hypertrophic cardiomyopathy in one patient; three patients had no structural heart disease. Patients received no antiarrhythmic therapy for at least 1 week before entry into the study. All were clinically stable before and during the 4-day monitoring period; outpatient activity routines and medical regimens were kept constant.
Avionics tapes were analyzed by an independent research service (Anthropometrics, Haddonfield, New Jersey) using an Avionics 660A Electrocardioscanner, a 662B2 Arrhythmia Analysis module and a 680 Minicomputer (with software package 17059). Two analysts processed each tape. In order to validate this analysis system and evaluate the information generated by the analog and digital processors, one 12-hour sample from each patient was analyzed in real-time (facilitated using an American Optical Trendscriber) and compared with the data derived by analyst interaction with the Avionics 660A computerized scanner. A sample of each designated ventricular ectopic complex was printed out and further verified by a cardiologist. Tapes were also.analyzed to determine the extent to which systematic "constant error" inputs might be introduced into the high-speed data extraction process. Such errors cause a greater percent deviation in handling data with lower frequencies of events (e.g., complexes of ventricular tachycardia). Data were grouped according to four ascending frequency bands and a relative weighting scale was 690 applied. The overall relative error rate for the semiautomated analysis compared with real-time was 7.5 ± 5% (SD): 6.9 + 6.1% (SD) for the analysis of couplets and 8.4 + 4.8% (SD) for the analysis of complexes of ventricular tachycardia. The error rate was calculated as the percentage difference from the realtime vs analyst-derived data.
For the purpose of this study, tapes were analyzed specifically to quantitate the mean hourly frequency of ventricular couplets and of ventricular tachycardia (three or more consecutive ventricular ectopic complexes). The conmputer software allowed for the quantification of the total hourly frequency of ventricular tachycardia or ventricular couplets, but did not permit analysis of individual episodes of ventricular tachycardia; for example, it was not possible to determine the extent of variability for runs of ventricular tachycardia that were three complexes vs those that were longer. The mean hourly frequency of couplets or ventricular tachycardia was then subjected to a fourfactor nested analysis of variance (pure Model II). 6 Analysis of variance can isolate the contribution of each of many components to the variation in a complex model. The standard deviation is the statistical measure of variation. The square of the standard deviation (the variance) is the means to distinguish among multiple sources of variation. A four-factor nested analysis of variance was applied to determine the extent to which variation in the frequency of couplets or ventricular tachycardia was attributable to variation "between patients," "between days" within patients, "between 8-hour periods" within days, and "between hours" within 8-hour periods. The "between-hours" analysis also included the "relative error rate compared with real-time." A maximum of 12 consecutive, 8-hour periods was available for analysis in each patient. For technical reasons, not all 8-hour periods were available for analysis. All patients had at least eight 8-hour periods available for analysis. The application of this statistical method for this purpose and the equations used to obtain the results presented have been described in detail. 5 Using a semiautomated computer-aided system of tape analysis, it was possible to quantify accurately the frequency of both ventricular tachycardia and couplets. However, when this study was conducted, limitations in this system of tape analysis precluded an analysis of the "R-on-T" phenomenon or multiform complexes. Therefore, for the purpose of this study, "complex" or "high-grade" arrhythmias only included ventricular ectopy occurring as ventricular couplets or ventricular tachycardia.
Results
The mean hourly frequency of ventricular tachycardia during each of the 8-hour monitoring periods for the 14 patients with this arrhythmia is given in table 1. The mean hourly frequency of ventricular tachycardia for each 4-day period and the total number of 8-hour periods (maximum eight to 12) in which ventricular tachycardia occurred are also listed.
Comparable data for the mean hourly number of ventricular couplets are detailed in table 2 for all 20 patients.
An analysis of the sources of variance in mean hourly ectopic frequency for both ventricular tachycardia and ventricular couplets is given in table 3. Using pooled data, the major source of variation in the frequency of ventricular couplets occurred "between patients" (64.5%); similarly, using pooled data, the major source of variation in the frequency of ventricular tachycardia was also "between patients" (46.2%); hour-to-hour variability, however, was also a major source of the total variance (38.0%).
Further analysis of the sources of variance in individual patients revealed that hour-to-hour variation in ectopic frequency accounted for 70.6% of the variance in the frequency of ventricular tachycardia and 64.2% of that in couplets. Variability in the mean hourly ectopic frequency for couplets and ventricular tachycardia was less marked when longer monitoring periods were compared: day-to-day variability contributed only 12.1% to the variance in mean hourly frequency of ventricular tachycardia and only 12.1% to the variance in mean hourly frequency of couplets.
Based on these variance data, statistical analysis was performed to determine the percent reduction in ectopic frequency required during a "test" period to demonstrate a statistically significant (p < 0.05) reduction in complex arrhythmias cornpared with a "control" period. Various protocols using 8-, 12-and 24-hour electrocardiographic monitoring periods with the required number of control and test period scans are detailed in table 4, along with the minimal percent reductions in ectopic frequency required at the 95% confidence level.
In addition, differences between 8-hour periods were analyzed to determine whether they were systematic or random. In comparing the third 8-hour period (midnight to 8 a.m.) of each monitoring period with the other two 8-hour periods, there was a statistically significant (p < 0.01) 20% decrease in complex arrhythmia frequency during sleep. This decrease in ectopic complexes exceeded the decrease in sinus beats during the midnight to 8 a.m. period. Further analysis of our data (tables 1 and 2) revealed no statistically significant correlation between the mean hourly frequency of all ventricular ectopic complexes and the mean hourly frequency of ventricular tachycardia or couplets. Nor was there a statistically significant correlation between the frequency of ventricular tachycardia and the underlying heart rate in any of the 14 patients with ventricular tachycardia or between the underlying heart rate and the frequency of ventricular couplets in 12 of 20 patients with ventricular couplets. In the eight others, there was a statistically significant (p < 0.01) correlation in which three patients had a negative correlation (patients 11, 13 More detailed information concerning the sources of variance will be furnished upon request. 
Discussion
This study documents that, in otherwise stable patients with frequent ventricular ectopy, including ventricular tachycardia and couplets, the frequency of these complex arrhythmias varies considerably. This variability is most marked "between hours" but also occurs "between successive 8-hour periods" and "between days" in patients during 4-day periods of continuous electrocardiographic monitoring. The variability in the frequency of ventricular tachycardia or couplets is less marked, however, than the variability reported in the mean hourly frequency of isolated unifocal ventricular ectopic complexes in patients with . 30 ventricular ectopic complexes/hour using similar methods of analysis.5 Thus, the percent reduction in ectopic frequency of complex arrhythmias necessary to document that a decrease is likely to be due to therapeutic effect (at the 95% confidence level, table 4) rather than to spontaneous variation is less than that required when ectopic frequency alone is considered. Thus, if one control 24-hour monitoring period in an individual patient is compared with one 24-hour treatment period, a 65% reduction in the mean hourly frequency of ventricular tachycardia and 75% reduction in the mean hourly frequency of couplets is required to show a statistically significant effect, whereas an 83% reduction would have been required if all ventricular ectopics were considered without regard for complexity. 5 Ruberman and co-workers7 showed that attention to high-grade arrhythmias in addition to ectopic frequency alone has particular relevance. They evaluated the number and types of ventricular ectopic complexes during a 1-hour monitoring period as possible markers for sudden death in a 3-year follow-up period of men with previous myocardial infarction and found no difference in mortality rates between those with only "simple" (unifocal, isolated) ventricular ectopic complexes and those free of all ventricular ectopy during monitoring. Furthermore, there was no increased risk shown by men with simple ventricular ectopic complexes of high frequency. Only men with complex arrhythmias had markedly increased mortality risk (28.3% vs 12.5% for those with simple ventricular ectopic complexes only) and risk of sudden coronary death (15.5% vs 4.2%) in the follow-up period. The presence of . 10 ventricular ectopic complexes/hour in addition to complex forms further increased these risks. 7 Our analysis, however, also shows the limitations of such studies based on limited monitoring periods. None of the 14 patients in our study with ventricular tachycardia had this arrhythmia recorded during each of the 8-hour periods monitored, and only four of 14 patients had ventricular tachycardia recorded in more than half of the 8-hour periods monitored. Only 11 of 20 patients with ventricular couplets had these recorded during each of the 8-hour periods monitored. Thus, even an 8-hour monitoring period may not detect all patients potentially at increased risk for sudden death. Moreover, the frequency of complex arrhythmias does not necessarily correlate with the mean hourly frequency for all ventricular ectopic complexes (tables 1 and 2). In addition, our results show marked spontaneous variability in the hour-to-hour frequency of ventricular tachycardia or couplets. Winkle4 reported similar results in comparing the frequency of ventricular ectopics, couplets and "salvos" during 1 1 consecutive half-hour periods of monitoring in a protocol designed to mimic acute drug 694 CIRCULATION testing. Because spontaneous variability from one half hour to another was so marked, complete disappearance of ventricular ectopics for 30 minutes or at least 90% reduction in ectopic frequency for at least 1 hour was required to attribute the effect to drug therapy. Thus, although it may be possible epidemiologically to identify populations at increased risk for sudden death with only limited monitoring, the marked variability in hour-to-hour frequency of complex arrhythmias cautions against extrapolating from such data to the therapy of individual patients. Moreover, both the short-term monitoring studies of Winkle4 and our long-term monitoring studies suggest that more stringent guidelines must be used to evaluate potential therapeutic regimens for individual patients, whether for clinical indications or on research protocols.5 For example, even comparing four 24-hour control monitoring periods with four 24hour test periods requires a 41% reduction in the mean hourly frequency of ventricular tachycardia and a 50% reduction in the mean hourly frequency of ventricular couplets to demonstrate therapeutic efficacy.
Analysis of our pooled data also revealed marked variability in the frequency of ventricular tachycardia and couplets in individual patients. This variability is so great that it may also be inadvisable to pool individual patient data to detect trends in ectopic frequency in evaluating new potential antiarrhythmic agents in groups of patients. Specifically, in extrapolating from pooled data to the analysis of individual patients within the group, the same rigorous methods outlined here must be applied to document therapeutic efficacy. This study also shows a statistically significant decrease in the frequency of complex ventricular arrhythmias during sleep (mid-night to 8 a.m.) compared with the rest of the day. There was essentially no statistically significant correlation between underlying heart rate and the frequency of complex ventricular ectopy. Finally, this analysis provides further documentation of the extent to which biologic variability may occur even under stable conditions in a series of quantitative clinical measurements.
